Many countries are expanding Covid-19 vaccine booster programs or shortening the gap between shots as governments scramble to shore up protection against the new Omicron variant which emerged during November in southern Africa and Hong Kong.
The World Health Organization listed AstraZeneca’s Covid-19 vaccine for emergency use, widening access in the developing world, while sources said the EU is in talks with Moderna on buying more vaccines.
The global tally of confirmed coronavirus cases hit 60 million on Nov. 25, with the pace of new infections accelerating and the United States reporting record numbers of hospitalizations, according to a Reuters tally.
W2O, a leading independent provider of analytics-driven technology-enabled marketing and communications solutions to the healthcare sector, announced the acquisition of Elysia Group, a health economic and outcomes research (HEOR) consulting firm operating in the United States and Asia Pacific.
Samsung Bioepis Co. Ltd. announced the company’s expansion in mainland China through a licensing agreement with C-Bridge Capital. The transaction covers multiple biosimilar candidates from Samsung Bioepis, including third-wave biosimilar candidates SB11 and SB12 – which reference Lucentis (ranibizumab) and Soliris (eculizumab) – as well as the biosimilar candidate SB3 that references Herceptin (trastuzumab).
Sanofi has signed a license deal with Hanmi Pharmaceutical to develop experimental, long-acting diabetes treatments, the French drugmaker said on Thursday, in a move to revive its diabetes division. […]
Leaders of India’s $15 billion pharmaceuticals industry, a major supplier of affordable generics to the world, have joined public health activists in criticizing a new U.S.-led trade deal they say […]
New HIV infections in India could rise for the first time in more than a decade because states are mismanaging a prevention program by delaying payments to health workers, the […]